Table 1. Mice with the chronic... | American Society of Hematology

Table 1.

Mice with the chronic myelogenous leukemia–like myeloproliferative disorder treated with STI571 demonstrate a marked reduction in white blood count and spleen weight

	STI571-treated^*	Placebo
WBC, average, ×10³/μL
Responding^†	23 (± 12)	409 (± 12)
All	153 (± 84)
Spleen weight, mg
Responding^†	290 (± 40)	864 (± 92)
All	320 (± 33)

	STI571-treated^*	Placebo
WBC, average, ×10³/μL
Responding^†	23 (± 12)	409 (± 12)
All	153 (± 84)
Spleen weight, mg
Responding^†	290 (± 40)	864 (± 92)
All	320 (± 33)

Standard errors are depicted in parentheses.

The data depicted are from the mice in Figure 2 and are representative of at least 3 independent bone marrow transplantation experiments.

†

Mice experiencing a hematologic response to STI571, recorded at time of analysis.

View Large

This Feature Is Available To Subscribers Only